The members of the Union of Ukrainian Entrepreneurs (SUP) visited the manufacturing site for solid dosage forms where they observed the technological processes.
The guests visited the new manufacturing site for solid dosage forms which was launched last year. The project implementation lasted for 2 years and cost the Company EUR 20 million. The launch of a new manufacturing site for solid dosage forms will double annual production capacity. Moreover, due to production increase, nearly 100 new jobs were created.
Today, every tenth pack of medicinal products that is used in our country is manufactured by Farmak.
Technical Director of Farmak Andriy Goy accompanied the guests through the entire technological cycle: from raw material acceptance to tablet compression.
Executive Director of Farmak Volodymyr Kostiuk shared the latest achievements of the Company during the conversation with the SUP members:
The period from the decision to launch a new product and batch shipment incidentally takes 3-4 years.
More than 20 % of the Company’s products are exported.
The Company has managed to increase production capacity by 25% over past five years. Moreover, Farmak is one of few Ukrainian companies developing its own chemical synthesis of active pharmaceutical ingredients (API) in Kyiv and in Shostka.
According to Volodymyr Kostiuk, staff loss is one of the challenges which Ukrainian companies face today.
“Today, we compete not only with Ukrainian manufacturers, but also with companies from Poland, Latvia and Lithuania. A lot of workers, including subject matter specialists, leave our country. We invest in the training of our employees and motivate them financially: over the last 5 years, the salaries we offer have grown 2.5 times”, said Volodymyr Kostiuk.
Over the last 20 years, more than USD 250 million have been invested in modernization and re-equipment. The Company has representative offices in five countries: Uzbekistan, Poland, Kazakhstan, Kyrgyzstan, Belarus.
The main values of the Company today are Quality, Growth, Professionalism, Engagement and Innovativeness.
The book Visionary (in Ukrainian: Vizioner («Візіонер»)) about Filya Zhebrovska, the owner of the largest Ukrainian pharmaceutical company Farmak, was published in April by Burda Publishing House. The biography tells about the life of a person who managed to steer the Soviet enterprise out of the crisis and transform it into a modern European manufacturing [...
Hospitals require primary support as they are not yet equipped with the devices necessary for effective treatment of COVID-19. The Zhebrivski Family Charitable Foundation paid for and now is expecting the delivery of three ORICARE V8600 lung ventilators (manufactured in the USA), purchased Acclarix LX8 digital ultrasound diagnostic system and other equipment...
The Zhebrivski Family Charitable Foundation (successor to the Farmak Charitable Foundation) provided each retired employee of Farmak with essential medicines The elderly people having retired from JSC Farmak will receive packages with protective masks and medicines. The packages include antiviral, sedative, anti-allergy medicines, as well as medicines for tr...